1P-AL-LAD

1P-AL-LAD

Clinical data
Other names	1-Propionyl-AL-LAD
Routes of administration	Oral
Drug class	Serotonergic psychedelic; Hallucinogen
Identifiers
IUPAC name (6aR,9R)-N,N-diethyl-4-propanoyl-7-prop-2-enyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
CAS Number	3028950-71-9 Y
PubChem CID	166091990
Chemical and physical data
Formula	C25H31N3O2
Molar mass	405.542 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCC(=O)N1C=C2C[C@@H]3C(=C[C@H](CN3CC=C)C(=O)N(CC)CC)C4=C2C1=CC=C4
InChI InChI=1S/C25H31N3O2/c1-5-12-27-15-18(25(30)26(7-3)8-4)13-20-19-10-9-11-21-24(19)17(14-22(20)27)16-28(21)23(29)6-2/h5,9-11,13,16,18,22H,1,6-8,12,14-15H2,2-4H3/t18-,22-/m1/s1 Key:GAGOTJNMWJYWMB-XMSQKQJNSA-N

1P-AL-LAD, also known as 1-propionyl-AL-LAD, is a derivative of lysergic acid diethylamide (LSD) which has psychedelic effects and has been sold as a designer drug.^[1] It is believed to act as a prodrug for AL-LAD and produces a head-twitch response in animal studies.^[2]

Analogues of 1P-AL-LAD include AL-LAD, 1cP-AL-LAD, 1T-AL-LAD, 1P-ETH-LAD, and 1P-LSD, among others.

1P-AL-LAD is not an explicitly nor implicitly controlled substance in Canada as of 2025.^[3]

1P-AL-LAD is not an explicitly controlled substance in the United States.^[4] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.

• Substituted lysergamide
• Lizard Labs

• 1P-AL-LAD - Isomer Design